Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.
4,54NOK
+2,71% (+0,12)
Päätöskurssi
Ylin4,68
Alin4,50
Vaihto
0,2 MNOK
4,54NOK
+2,71% (+0,12)
Päätöskurssi
Ylin4,68
Alin4,50
Vaihto
0,2 MNOK
4,54NOK
+2,71% (+0,12)
Päätöskurssi
Ylin4,68
Alin4,50
Vaihto
0,2 MNOK
4,54NOK
+2,71% (+0,12)
Päätöskurssi
Ylin4,68
Alin4,50
Vaihto
0,2 MNOK
4,54NOK
+2,71% (+0,12)
Päätöskurssi
Ylin4,68
Alin4,50
Vaihto
0,2 MNOK
4,54NOK
+2,71% (+0,12)
Päätöskurssi
Ylin4,68
Alin4,50
Vaihto
0,2 MNOK
2025 Q3 -tulosraportti

Vain PDF

82 päivää sitten

Tarjoustasot

NorwayEuronext Growth Oslo
Määrä
Osto
20 000
Myynti
Määrä
10 000

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
100--
5--
10 000--
3 406--
850--
Ylin
4,68
VWAP
-
Alin
4,5
VaihtoMäärä
0,2 39 430
VWAP
-
Ylin
4,68
Alin
4,5
VaihtoMäärä
0,2 39 430

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2025 Q4 -tulosraportti
12.2.
Menneet tapahtumat
2025 Q3 -tulosraportti13.11.2025
2025 Q2 -tulosraportti14.8.2025
2025 Q1 -tulosraportti10.4.2025
2024 Q4 -tulosraportti13.2.2025
2024 Q3 -tulosraportti14.11.2024

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    INDUCT is this week's stock in Investornytt,....things are starting to heat up.
    21 t sitten
    ·
    21 t sitten
    ·
    Who is the buyer last 3 months? The company has had strong development last 3 months. Now Investornytt can reveal who is behind the strong buying interest in the company. Hanne Merethe Gaarder Almgren has recently bought into the company to become the company's 6th largest shareholder. She is the wife of the more well-known financier Bengt Almgren who in turn is said to be known by several in the environment around the company. In 2017, Nettavisen wrote this article summarizing Bengt Almgren's achievements in the financial markets. In 2008, Almgren had to leave his wife's limited company, the ringtone company Eurobate, which reported him to Økokrim for having caused the company millions in losses after stock trades. The case was never investigated. In 2009, DNB filed for bankruptcy with a claim of 30–40 million, but found that there was nothing to collect. In 2014, Almgren was declared personally bankrupt by the debt collection company Lindorff in Oslo City Court. He then had an outstanding debt collection claim from DNB of 4.2 million kroner from 2011 and was subject to wage garnishment. Interesting observation It is important to explain that Hanne Merethe Gaarder Almgren is Bengt's wife. There is no reason to believe that there are any irregularities behind the Almgren family's stock purchases. But it is worth knowing for niche investors that these two are related. The real owner and decision-maker could be Bengt, who has previously been in the spotlight. I consider this positive that he chooses to be a major shareholder with potentially camouflaged ownership. He is a former head of equities, has a broad network in Oslo, connections to someone on the board of Induct, and was reported in 2008 for stock trades. There is an expression that says a trickster does not trick a trickster. Thus, I believe something might be brewing in the company. I have tried to speak with the company, which has been very difficult to reach and does not want to talk about anything. Almgren entered the company in a share issue and has since increased his positions. The most interesting thing is that one sees players who previously sold shares in the company starting to increase their positions again. NPP Capital increases One of the founders of Induct, Alf Martin Johnsen, owns shares through his wholly-owned limited company, NPP Capital. He has sold shares for a long time, but has been quiet (not sold positions) in the last month. In addition, one actually sees from the lists that he has started increasing again. Even with a few thousand shares, which one should not attach much importance to. The collaboration with AstraZeneca is undoubtedly the strongest price driver for Induct right now. It has moved the company from being a small Norwegian player to becoming a strategic partner for one of the world's largest pharmaceutical giants. Here is a summary of why this collaboration is so crucial and what it entails
  • 29.1.
    ·
    29.1.
    ·
    I guess it's soon the last opportunity to buy at these levels. I believe a signature with az is quite close! Looking forward to the day induct reports about a new agreement with the giant 😎😎🚀😁
    2 päivää sitten
    ·
    2 päivää sitten
    ·
    Impossible to say. If there will even be an agreement 😊 But that there is enormous potential - we are probably all agreed on…
  • 26.1.
    ·
    26.1.
    ·
    Yes, then it's the q4 report in approx. 3 weeks. One waits in anticipation...
  • 20.1.
    ·
    20.1.
    ·
    Now, I suppose, some information will probably be coming soon.
    21.1.
    ·
    21.1.
    ·
    I hope it's not a sign that someone has gotten hold of information the rest of us don't have😳
    21.1.
    ·
    21.1.
    ·
    No, I just think some people are getting tired of waiting. I bet an analysis will come before the Q4 presentation. I wouldn't be surprised if it's around 10 kroner if it comes before the agreement, only to then be adjusted up to 15-20 kroner when the agreement is in place. After that, I believe more analyses will follow. Induct will soon appear in a completely new guise with subsequent repricing. Of course, nothing comes for free, the company must prove that they can scale if the share price is to rise through 2026.
  • 15.1.
    ·
    15.1.
    ·
    Don't understand the decline on that news. It has little or no impact on the company.
    20.1.
    Storm in the teacup
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q3 -tulosraportti

Vain PDF

82 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    INDUCT is this week's stock in Investornytt,....things are starting to heat up.
    21 t sitten
    ·
    21 t sitten
    ·
    Who is the buyer last 3 months? The company has had strong development last 3 months. Now Investornytt can reveal who is behind the strong buying interest in the company. Hanne Merethe Gaarder Almgren has recently bought into the company to become the company's 6th largest shareholder. She is the wife of the more well-known financier Bengt Almgren who in turn is said to be known by several in the environment around the company. In 2017, Nettavisen wrote this article summarizing Bengt Almgren's achievements in the financial markets. In 2008, Almgren had to leave his wife's limited company, the ringtone company Eurobate, which reported him to Økokrim for having caused the company millions in losses after stock trades. The case was never investigated. In 2009, DNB filed for bankruptcy with a claim of 30–40 million, but found that there was nothing to collect. In 2014, Almgren was declared personally bankrupt by the debt collection company Lindorff in Oslo City Court. He then had an outstanding debt collection claim from DNB of 4.2 million kroner from 2011 and was subject to wage garnishment. Interesting observation It is important to explain that Hanne Merethe Gaarder Almgren is Bengt's wife. There is no reason to believe that there are any irregularities behind the Almgren family's stock purchases. But it is worth knowing for niche investors that these two are related. The real owner and decision-maker could be Bengt, who has previously been in the spotlight. I consider this positive that he chooses to be a major shareholder with potentially camouflaged ownership. He is a former head of equities, has a broad network in Oslo, connections to someone on the board of Induct, and was reported in 2008 for stock trades. There is an expression that says a trickster does not trick a trickster. Thus, I believe something might be brewing in the company. I have tried to speak with the company, which has been very difficult to reach and does not want to talk about anything. Almgren entered the company in a share issue and has since increased his positions. The most interesting thing is that one sees players who previously sold shares in the company starting to increase their positions again. NPP Capital increases One of the founders of Induct, Alf Martin Johnsen, owns shares through his wholly-owned limited company, NPP Capital. He has sold shares for a long time, but has been quiet (not sold positions) in the last month. In addition, one actually sees from the lists that he has started increasing again. Even with a few thousand shares, which one should not attach much importance to. The collaboration with AstraZeneca is undoubtedly the strongest price driver for Induct right now. It has moved the company from being a small Norwegian player to becoming a strategic partner for one of the world's largest pharmaceutical giants. Here is a summary of why this collaboration is so crucial and what it entails
  • 29.1.
    ·
    29.1.
    ·
    I guess it's soon the last opportunity to buy at these levels. I believe a signature with az is quite close! Looking forward to the day induct reports about a new agreement with the giant 😎😎🚀😁
    2 päivää sitten
    ·
    2 päivää sitten
    ·
    Impossible to say. If there will even be an agreement 😊 But that there is enormous potential - we are probably all agreed on…
  • 26.1.
    ·
    26.1.
    ·
    Yes, then it's the q4 report in approx. 3 weeks. One waits in anticipation...
  • 20.1.
    ·
    20.1.
    ·
    Now, I suppose, some information will probably be coming soon.
    21.1.
    ·
    21.1.
    ·
    I hope it's not a sign that someone has gotten hold of information the rest of us don't have😳
    21.1.
    ·
    21.1.
    ·
    No, I just think some people are getting tired of waiting. I bet an analysis will come before the Q4 presentation. I wouldn't be surprised if it's around 10 kroner if it comes before the agreement, only to then be adjusted up to 15-20 kroner when the agreement is in place. After that, I believe more analyses will follow. Induct will soon appear in a completely new guise with subsequent repricing. Of course, nothing comes for free, the company must prove that they can scale if the share price is to rise through 2026.
  • 15.1.
    ·
    15.1.
    ·
    Don't understand the decline on that news. It has little or no impact on the company.
    20.1.
    Storm in the teacup
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

NorwayEuronext Growth Oslo
Määrä
Osto
20 000
Myynti
Määrä
10 000

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
100--
5--
10 000--
3 406--
850--
Ylin
4,68
VWAP
-
Alin
4,5
VaihtoMäärä
0,2 39 430
VWAP
-
Ylin
4,68
Alin
4,5
VaihtoMäärä
0,2 39 430

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2025 Q4 -tulosraportti
12.2.
Menneet tapahtumat
2025 Q3 -tulosraportti13.11.2025
2025 Q2 -tulosraportti14.8.2025
2025 Q1 -tulosraportti10.4.2025
2024 Q4 -tulosraportti13.2.2025
2024 Q3 -tulosraportti14.11.2024

Tuotteita joiden kohde-etuutena tämä arvopaperi

2025 Q3 -tulosraportti

Vain PDF

82 päivää sitten

Uutiset

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Datan lähde: FactSet, Quartr
Seuraava tapahtuma
2025 Q4 -tulosraportti
12.2.
Menneet tapahtumat
2025 Q3 -tulosraportti13.11.2025
2025 Q2 -tulosraportti14.8.2025
2025 Q1 -tulosraportti10.4.2025
2024 Q4 -tulosraportti13.2.2025
2024 Q3 -tulosraportti14.11.2024

Tuotteita joiden kohde-etuutena tämä arvopaperi

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 2 päivää sitten
    ·
    2 päivää sitten
    ·
    INDUCT is this week's stock in Investornytt,....things are starting to heat up.
    21 t sitten
    ·
    21 t sitten
    ·
    Who is the buyer last 3 months? The company has had strong development last 3 months. Now Investornytt can reveal who is behind the strong buying interest in the company. Hanne Merethe Gaarder Almgren has recently bought into the company to become the company's 6th largest shareholder. She is the wife of the more well-known financier Bengt Almgren who in turn is said to be known by several in the environment around the company. In 2017, Nettavisen wrote this article summarizing Bengt Almgren's achievements in the financial markets. In 2008, Almgren had to leave his wife's limited company, the ringtone company Eurobate, which reported him to Økokrim for having caused the company millions in losses after stock trades. The case was never investigated. In 2009, DNB filed for bankruptcy with a claim of 30–40 million, but found that there was nothing to collect. In 2014, Almgren was declared personally bankrupt by the debt collection company Lindorff in Oslo City Court. He then had an outstanding debt collection claim from DNB of 4.2 million kroner from 2011 and was subject to wage garnishment. Interesting observation It is important to explain that Hanne Merethe Gaarder Almgren is Bengt's wife. There is no reason to believe that there are any irregularities behind the Almgren family's stock purchases. But it is worth knowing for niche investors that these two are related. The real owner and decision-maker could be Bengt, who has previously been in the spotlight. I consider this positive that he chooses to be a major shareholder with potentially camouflaged ownership. He is a former head of equities, has a broad network in Oslo, connections to someone on the board of Induct, and was reported in 2008 for stock trades. There is an expression that says a trickster does not trick a trickster. Thus, I believe something might be brewing in the company. I have tried to speak with the company, which has been very difficult to reach and does not want to talk about anything. Almgren entered the company in a share issue and has since increased his positions. The most interesting thing is that one sees players who previously sold shares in the company starting to increase their positions again. NPP Capital increases One of the founders of Induct, Alf Martin Johnsen, owns shares through his wholly-owned limited company, NPP Capital. He has sold shares for a long time, but has been quiet (not sold positions) in the last month. In addition, one actually sees from the lists that he has started increasing again. Even with a few thousand shares, which one should not attach much importance to. The collaboration with AstraZeneca is undoubtedly the strongest price driver for Induct right now. It has moved the company from being a small Norwegian player to becoming a strategic partner for one of the world's largest pharmaceutical giants. Here is a summary of why this collaboration is so crucial and what it entails
  • 29.1.
    ·
    29.1.
    ·
    I guess it's soon the last opportunity to buy at these levels. I believe a signature with az is quite close! Looking forward to the day induct reports about a new agreement with the giant 😎😎🚀😁
    2 päivää sitten
    ·
    2 päivää sitten
    ·
    Impossible to say. If there will even be an agreement 😊 But that there is enormous potential - we are probably all agreed on…
  • 26.1.
    ·
    26.1.
    ·
    Yes, then it's the q4 report in approx. 3 weeks. One waits in anticipation...
  • 20.1.
    ·
    20.1.
    ·
    Now, I suppose, some information will probably be coming soon.
    21.1.
    ·
    21.1.
    ·
    I hope it's not a sign that someone has gotten hold of information the rest of us don't have😳
    21.1.
    ·
    21.1.
    ·
    No, I just think some people are getting tired of waiting. I bet an analysis will come before the Q4 presentation. I wouldn't be surprised if it's around 10 kroner if it comes before the agreement, only to then be adjusted up to 15-20 kroner when the agreement is in place. After that, I believe more analyses will follow. Induct will soon appear in a completely new guise with subsequent repricing. Of course, nothing comes for free, the company must prove that they can scale if the share price is to rise through 2026.
  • 15.1.
    ·
    15.1.
    ·
    Don't understand the decline on that news. It has little or no impact on the company.
    20.1.
    Storm in the teacup
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

NorwayEuronext Growth Oslo
Määrä
Osto
20 000
Myynti
Määrä
10 000

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
100--
5--
10 000--
3 406--
850--
Ylin
4,68
VWAP
-
Alin
4,5
VaihtoMäärä
0,2 39 430
VWAP
-
Ylin
4,68
Alin
4,5
VaihtoMäärä
0,2 39 430

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt